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Prevalence of Anti-HEV Antibodies in 
Hemophilicacs Patients 
E Mesa, A. Guerra-Neira, P. Campo, S. Cmchaga, 
R. Martinez-Zapico. o p t .  ojMicrobiology, La Paz Hospital, Madrid, 
Spain 
Objectives: At the present time, with the testing of all donated 
blood and source plasma for hepatitis B virus (HBV), hepatitis C 
virus (HCV) and human immunodeficiency virus (HIV), the trans- 
mission of these viruses by blood or blood products is now rare. In 
conmt  to HBV and HCV, there are only a few accounts of t r a n s -  
mission of hepatitis E virus (HEV) and hepatitis A virus (HAV) by 
blood transfusion. The aim of the study is to know the prevalence of 
antibodies to HEV in a high risk group U e  hemophilicacs. 
Methods: We tested 90 serum samples kom hemophilicacs pa- 
tients by enzyme immunoassay for IgG anti-HAV and anti HBc 
(Sorin Biomedica), IgG anti-HEV (Abbott), anti-HCV (Sanofi Pas- 
teur), and anti-HIV (Behring). 
Results: The results are shown in the table 
n (%) 
IgGann-HAV 42 (46.6%) 
Anti-HCV 35 (38.8%) 
Anti-HBc 7 (8.1%) 
Ann-HIV 14 (15.5%) 
IKGmti-HEV 4 (4.4%) 
Conclusions: The prevalence of serum antibodies to HEV in 
hemophilicacs (4.4%) is similar to healthy adults (4%) in Spain. These 
data suggest that there is not evidence of parented transmission of 
HEY 
I P978 I Evolution of "Quasispecies" of Woodchuck 
Hepatitis B Virus During the Early Phases of 
Experimental Infection 
C. Argentini, V. La Sorsa, E. D'Ugo, R. Bruni, R. Giuseppetti, 
M. Rapicetta. Lab. of Krology, Ish'tuto Superiore di Sanitd, Rome, Italy 
Objectives: Aim of the work was to characterize the "quasispecies" 
nature of WHV (animal model of hepatitis B virus), and to study its 
evolution during the early phases of the mfection. 
Methods: Serum samples from an experimentally dected wood- 
chuck were collected weekly during the first 3 months of the in- 
fection. Clones (T-vector method) of amplified (nt 2490-419) PreS 
regions of WHV genome were sequenced (37313 ABI automatic se- 
quencer). Phylogenetic analysis was performed using the GCG and 
PHYLIP packages. 
Results: The viral "quasispecies" was present, at the beginning of 
the infection, as well defined variants related but clearly distinguish- 
able from the inoculum (derived from WHV7) variants. The popu- 
lations found in the sera collected 45 and 52 days post mfection are 
homogeneous and highly related to the prototype WHW. In con- 
trast those found 30 and 67 days post-inoculum are heterogeneous 
and less related to WHW. In the serum of 30 days post-inoculum 
sequences of 50% of the clones c o w  for a truncated presl-pres2 
protein. Heterogeneity of truncated mutants was found in the other 
follow up sera. 
Conclusions: The Merences of the "quasispecies" viral popda- 
tion in follow-up sera have shown that the evolution is very dynamic, 
&o during short time intervals with a fast adaptation of WHV in 
response to the environment (the host) changes. The truncated pre-S 
mutants can be involved in the establishment of the chronic infec- 
tion. 
SeNm Thymidine Kinase Levels in Patients with 
Acute Viral Hepatitis A and 6 
M. Siinbiil, A. Be&, C. Erogu, 2. Akpm, B. Adam, H. Ozdener, 
H. Leblebiciogu. Ondokuz Mayis University, Medical School, Samsun, 
Turkiye 
Objective: To evaluate the clinical applications of serum thymidine 
hnase (TK) activity in acute viral hepatitis 
Methods: We compared the TK levels with liver function tests 
such as aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), gamma glutamyl transpeptidase (GGT), alkaline fosfatase in 
50 patients with acute viral hepatitis (29 with type B and 21 with 
type A) and in 22 normal controls. During the acute stage of the 
viral hepatitis, serum TK activity increased significantly in both types 
of hepatitis compared with control (p < 0.0001) and also serum 
TK levels in hepatitis A (16.05 f 15.08 IU/l) (mean f SD) were 
higher than those in hepatitis B (12.61 f 19.04 IU/l) (p < 0.05). 
No significant correlation was observed between serum TK activity 
and finding for AST, ALT, GGT, total and direct bilirubin, serum 
albumin, and globulin in patients with hepatitis A. However, TK 
was correlated with the activity of ALP (rs = 0.59, p < 0.005). As 
to hepatitis B, the only correlation was found between TK and total 
b h b i n  level (r, = -0.39, p < 0.05). 
Conclusion: Our data suggest that a marked elevation of serum 
TK activity may provide a marker for acute wal hepatitis, especially 
type A. 
Hepatitis C 
Ip9801 Evaluation of Automated COBAS AMPLICOR 
M. Poljak, K. Seme, S. Koren. Institute ofMicrobiology, Ljubljana, 
Slovenia 
Objectives: To evaluate the COBAS Ah4PLICOR PCR system 
(Roche Diagnostic Systems) for detection ofhepatitis C virus (HCV) 
RNA in serum samples. The manual Roche AMPLICOR microwell 
plate HCV Test was the reference method. 
Methods: A total of 245 serum samples, 54 previously deter- 
mined as HCV RNA negative (all anti-HCV positive), and 191 
HCV RNA positive samples were included in the study. Among 
HCV RNA positive samples, 14 samples had bellow 2.000 copies 
of HCV RNNml, 18 samples between 2.000-15.000, 15 samples 
between 15.00G50.000, 28 samples between 50.000-100.000, and 
116 samples more than 100.000 copies of HCV RNA/ml, as deter- 
mined by AMPLICOR HCV Monitor assay. Using Inno LiPa HCV 
I1 assay, HCV RNA was typed in 94 samples as HCV subtype 1 b, in 
44 as genotype 3, in 36 as subtype l a ,  in 11 as subtype 2c, in five as 
subtype Zb, and in one sample as genotype 4. 
Results: For 245 samples tested, there was 100% concordance 
between the results of the manual AMPLICOR PCR system and 
the automated COBAS AMPLICOR system. 
Conclusion: The automated COBAS AMPLICOR system pro- 
vide the &cal microbiology laboratory with specific and sensitive 
PCR method for rapid and reliable detection of HCV RNA. 
Hepatitis C WNS PCR System 
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I P981 1 Evaluation of a New Assay for Detection of HCV 
IgM Antibodies 
M. Ferrero, M. Cebolledo, E. Gazapo. Microbiology Dept., San Jorge 
General Hospital, Huesca, Spain 
Objective: To evaluate the performance of a new HCV-IgM core 
test in serum samples h m  HCV positive patients, blood donors and 
in specimens with potential interfering substances. 
Methods: We studied 233 anti-HCV positive patients (median 
age 36 yrs,. range 15-86, M/F 156177). The diagnose was based on 
serological markers for HCV (anti-HCV IgG detected by the second 
generation MATRIX HCV, Abbott Diagnostika, Wiesbaden, Ger- 
many). Almost 16% of the patients were treated with IFN alpha-2a. 
Determination of serum ALT and HCV RNA were performed 
(Amplicor, Roche Lab., Basel, Switzerland). In each case IgM dass 
antibody to the putative structural (core) protein of HCV was eval- 
uated (Abbott HCV IgM EIA 2.0, Abbott Diagnostika, Wiesbaden, 
Germany). To evaluate the HCV IgM test specificity we analyzed 
57 blood donors and 70 serum samples with potential interfering 
substances (CMV, EBV, HAV, HBV or RF positive). 
Results: All 233 patients had anti-HCV core IgG antibodies 
detected by MATRIX HCV. Anti-HCV IgM antibodies were de- 
tected in 62%. Just over 58% were PCR-positive for HCV RNA. 
No sigruficant Merences were observed between IgM-positive and 
IgM-negative cases regarding the age, sex ratio and features of liver 
disease such as mean serum ALT, while a significant Merence was 
found in HCV RNA (Fisher's exact test: p < 0.05). The specificity 
of the IgM assay was calculated in 57 blood donors (95%) and in 70 
CMV, EBV, HAV, HBV or RF positive specimens (93%). 
Conclusions: The HCV IgM assay is highly specific for HCV 
viraemia and is a cheap and easy indicator of active wal replication. 
The test showed an acceptable specificity in blood donors and in 
specimens with potential interfering substances. 
m] HTLV-1/11 and HCV Prevalence in Dermal Patients 
M. Sankov, M. Bobkova, A. Bobkov. D I  Iuanousky Institute .f 
Kroloa, Moscow, Russia 
Objective: To study the presumed potential risk p u p s  for these 
infections in Moscow population. 
Methods: The cohort of 685 patients with Merent dermal dis- 
eases was investigated for the presence of HTLV-1/11 and HCV mfec- 
tions. The in-house EL4 test systems based on recombinant antigens 
were used for primary screening the sera. Western blot tests were 
applied for confirmation the positive screening results. 
Results: There were no true positive HTLV-1/11 samples in the 
group studied. HCV antibodies were found in 1.2% (8/685) of pa- 
tients. 
Conclusion: the dermal patients couldn't be considered as a risk 
p u p  for HTLV-1/11 infection at least in Moscow region. HCV 
semprevalence in this site corresponds to the average meaning in the 
population studied. 
in Moscow, Russia 
1 P983 I HCV-RNA Prevalence in Dialysis Patients 
A. Arzu Saymer, S. Erensoy, A. Zeytino& T. Ozacar, 
M. Ozkahya, E. Ok, E Akecek, A. Bdgq. Medical Faculty, Ege 
University, t m i r ,  Turkey 
Objectives: a) To assess the prevalence of HCV-RNA positivity in 
dialysis patients (DP) and its relation with anti-HCV seropositivity. 
b) To identlfy the risk factors for HCV infection in DPs. 
Methods: 52 hemodialysis (HD), 20 CAPD and 11 C U D +  
short-term hemoddysis patients were evaluated. Blood samples were 
tested for HCV-RNA (Roche) and for anti-HCV antibody by 3rd 
generation EIA and h e  immunoassay (Organon). Relationships be- 
tween HCV infection and duration and type of dialysis, ALT el- 
evation, HBV infection status and blood transfusion history were 
evaluated. 
Results: The prevalence of anti-HCV seropositivity was 34% and 
that of HCV viremia was 24%. HCV-RNA was present in 70% 
(19/27) of anti-HCV positive and in 1.8% (1/55) ofanti-HCV neg- 
ative DPs. The patient who had HCV-RNA positivity without the 
presence of anti-HCV antibody had recently received blood trans- 
fusions. HCV infection was sigdicantly more prevalent in the HD 
group and correlated with the duration of dialysis, ALT elevation and 
blood hansfusion and/or renal ansplantation (tx) history. None of 
the patients without HCV infection had elevated ALT levels. HCV 
mfection was not associated with any history of blood transfuuon 
and/or renal tx in one CAPD and 3 HD patients. 
Conclusion: HCV-RNA detection was found to be useful only 
in acute HCV infection in DPs. 
I P984 I Epidemiology of Hepatitis C WNS Infection 
among Intravenous Drug Users and among 
Haemotransfused Patients 
E. Minola, R. Tambini, G.P. Quinzan, G. Gavazzeni, M. Fusini, 
A. Capelli, B. Giussani, 0. Vicari Department OfInfeaiooUz Disemes, 
Ospedali Riuniti, Bergamo, Ifalx 'Immunohaem. Sm., Ozpedali Riuniti, 
Bergamo, Italy 
A i m s :  The cknico-pathological features of hepatitis C virus mfec- 
tion in intravenous drug users (IVDUs) are Merent h m  those 
found in other hepatitis C virus-mfected patients. Our aim was to 
test whether specific viral miants circulate within this particular 
patient population. 
Methods: We studled retrospectively the distribution of hepatitis 
C virus genotypes in 84 consecutive drug addica HCV Ab positive, 
HIV Ab negative; 60 men and 24 women, aged 21-44 (mean 30.5 
years old), followed at our institution in the period 1991-1996. All 
pa. had chronic hepatitis and diagnosis was histologically-proven 
in 78 pts. (92.9%). We also studied the distribution of hepatitis C 
virus genotypes in 58 patients, with anamnestic haemotransfusions 
(before 1990), HCV Ab positive and HIV Ab negative; 30 men and 
28 women, aged 23-58 (mean 41.6 years old). All pts. had chronic 
hepatitis and ckagnosis was histologically-proven in 52 pts. (89.7%). 
The genotypes were determined according to the method described 
by Simmonds. 
Results: 
Gcnoolpcs IVDUs (84 PO.) Hacmomnsfuwd (58 PO.) 
12 26 
lb 6 
2 2 
31 43 
4 7 
4 
33 
15 
6 
0 
p < 0.001 
p c 0.001 
p < 0.001 
p < 0.001 
~~ 
Conclusions: Hepatitis C virus type l a  and 3a infections were 
more fkquent among IVDUs than in haernotransfused patients; 
these findings suggest that hepatitis C virus types la and 3a were 
recently introduced in Italy, presumably via needle-sharing among 
IVDUs, and h m  t h s  reservoir they are likely extendmg to the 
general population, particularly among younger subjects. 
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Rend rrmplant rccipientr: 1 P985 1 Hepatitis c Vhus in Pregnancy: Seroprevalence 
E. Minola, R. Tambini, G. Gavazzeni, M. Teani, G. Axnuso, 
€? Bertulem, 0. Vicari, V. Perani. Depart. oflnfectious Diseares and 
" H C V  Vertical Fansm. Study Gr.", Osp. Riuniti, Bergamo, Itafy 
Objectives: Our purpose was to define the prevalence of antibodies 
to hepatitis C virus (HCV) among pregnant women. We also sought 
to examine both the reliabllity of traditional hepatitis risk factors 
among these women and the incidence of coinfection with other 
blood-borne transmissible agents. 
Methods: During September 1, 1994-0ctober 31, 1996, 7450 
consecutive pregnant women were screened, over 26 months, for 
HCV antibodies by a ELISA-3 method at 2 antenatal Departments 
in Bergamo; viral RNA was assessed by RT nested PCR in anti 
HCV positive (fve) mothers and genotypes (according to Simmonds 
classification) were assessed in these. Also the pregnant women were 
screened for HBsAg. 
Results: One hundred seventy-eght (2.4%) mothers, aged be- 
tween 20 and 43 years (mean = 30.8 years old), were anti HCV 
+ve to date. Five were also HE3sAg +ve and 7 patients were HIV 
Ab +ve. Chronic C hepatitis was diagnosed in 112 patients (62.9%); 
these patients had ALT serum levels > 1.5 times the normal values in 
more than 2 conaols before pregnancy and all of these women were 
fve for HCV-RNA. Genotypes assessed in 111 mothers were: 31 
= 3a (27.9%), 29 =: l b  (26.1%), 26 = 2a (23.4%), 15 = l a  (13.5%), 
5 gen. 4 (4.5%) and 5 were indeterminable (4.5%). Risk factors for 
HCV infection were identifiable in 105 patients (59.0%): 1) 52 were 
intravenous drug users (49.5%); 7 patients were also HIV fve. 2) 30 
had been haemotransfused (28.6%), before 1990.3) 14 were medtcal 
care workers (13.3%). 4) 9 were sexual partners of intravenous drug 
users HCV +ve patients. None risk factors for HCV infection were 
in 78 patients (41.0%). 
Conclusions: Anti-HCV antibodies were detected in 2.4% of 
7450 pregnant women screened. Drugs abuse, haemotransfkions 
and healthcare workers were the most commonly identified risk 
factors for anti-HCV positivity. HCV infection among pregnant 
women, with its potential for maternal-fetal transmission, represents 
a public health issue for more extensive study. 
and Risk Factors 
I P986 I Prevalence and Incidence of Hepatitis C in 
Haemodialysis and Renal Transplant Patients 
R. Watschinger, C. Luger, C. Jebelean, L. Binder, M. Haktsch, 
H.K. Stummvoll', H. Mittermayer. Deptc. ofMed. Minobiology G 
Hygiene, 'Internal Medicine 111 Elisabethinen Hospital Linz, Aucfria 
Infection with hepatitis C virus is common in patients on renal 
replacement therapy. Prevalence data fiom countries throughout Eu- 
rope range between 5% and 50%. In our nephrology department we 
screened all haemodialysis (HD) and renal transplant (TPX) patients 
for HCV antibodies by ELISA ((HCV EIA, Abbott) and for virus 
RNA by PCR (Amplicor Roche). 
Analysis of a constant group of HD (N = 89) and of TPX (N = 
102) patients screened throughout all three years showed an annual 
increase in the rate of HCV infection of 3% and 2%, respectively. 
Because HD and TPX patients have an increased risk of HCV 
infection as compared to the normal population regular screening is 
YCX 1994 1995 1996 
N tcrtcd 156 149 I77 
anti HCV por 25 (16%) 
anti HCV neg PCR por 0 0 2 
27 (18%) 30 (17%) 
Year 1994 1995 1996 
N tested 111 114 114 
m n  HCV ncg PCR por 5 4 4 
ann HCV pos 12 (11%) 16 (14%) 14 (1%) 
highly recommended. To improve the sensitivity of the detection of 
infected patients a combination of antibody testing and PCR should 
be used. 
w1 HCV Infection in Patients with p Thalasemia 
Major in Taiwan 
C.-T. Peng, C.-H. Tsai, E-J. Tsai. Deportment ofPediafrics, China 
Medical College Hospital, Taichung, Taiwn 
Objectives: Using ELISA-I1 (Abott) and PCR method to de- 
termine the prevalence of hepatitis C vim among polytransfused 
B-thalasemia major patients. 
Methods: In 26 males and 21 females with mean age 12.1 years 
(range 1-26 y/o) B-thalasemia major patients on long term transfu- 
sional and iron chelation therapy were studied. Anti HCV antibodies 
were assayed by a 2nd-generation ELISA, if positive, HCV RNA was 
detected by the RT PCR. An evaluable liver biopsy was available in 
8 cases with active wal replication patients (HCV RNA+), and was 
examined for histological diagnosis. Plasma aspartate amino trans- 
ferase (AST) was measured by autoanalysis (normal 17-40 U/L) and 
serum ferritin by immuno-radiometric method (normal range: male 
30-233;female 6-81 ug/I). The number of transfusions was ascer- 
tained fiom family interviews or h m  hospital files where possible. 
Resulw Out of 47 patients, 31 of them (66%) had anti HCV 
Ab detectable by ELISA 11, HCV RNA was present in 18 out of 
31 (58%) sera containing Anti HCV, which suggests an ongoing vi- 
ral replication in these patients. The HCV FWA positive patients 
showed sigmficantly higher plasma aspartate aminotransferase activ- 
ities (AST), mean (SD) 93.6 (42.1) u/l, and serum ferritin concen- 
trations, 5138 (2807) ug/l, than the anti-HCV seronegative (HCV 
RNA (-)) (AST 38.9 (17.8) u/l; serum ferritin 3051 (2431) u/l), 
respectively. Liver biopsies were obtained h m  8 patients positive 
for HCV RNA. Liver pathology in these cases was compatible with 
chronic persistent hepatitis. 
Conclusions: (1) H C V  is a major cause of chronic hepatitis in 
patients with B thalasemia major. (2) Higher AST activity and serum 
ferritin concentration is noted in HCV RNA positive patients. (3) 
The high prevalence of hepatitis C v i m  infection in B-thalasemia 
major patients, seems to be associated with the number and period 
of blood transfusions. 
I P988 I Prevalence of HCV Serotypes in the Dfferents 
Risk Groups of the Spanish Population 
€? Alonso Alonso, A. Orduiia, A. San Miguel, J.M. Eiros, 
M. Cuervo, M.A. Bratos, A. Rodriguez Torres. Dpto Microbiologi'a, 
Hospital Uniuersitario, Valladolid, Hospital Comarcal de Monjorte de 
Lemos, Lugo, Spain 
Objectives: To know the prevalence of the hepatitis C virus (HCV) 
serotypes in the Merents risk groups in Spain. 
Material and Methods: We studied the distribution of HCV 
serotypes in 118 patients of chronic hepatitis C. Of these, 51 were 
patients of unknown cause (UC), 12 were haemodyahsis patients, 
17 were blood transfusion recipients and 38 were intravenous drug 
users (IDUs). A second generation EIA (Abbott laboratories, USA) 
was used to screen for antibodies against HCA, and immunoblot 
(HCV Deciscan, Pasteur, France) was used to confirm the presence 
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of anti-HCV antibodies. To detect antibodies to the Werent HCV 
serotypes we used an immunoassay technique (Murex). 
Results: The most prevalent serotype was type 1 (75.3% of the 
patients) (62.1 of the IDUs patients, 80% of the blood transfUsion 
recipients, 100% of haemodyaksis patients and 75.7% of the UC pa- 
tients); serotype 3 w a s  present in 9.7% ofthe patients (13.8% in IDUs 
and 10.8% in UC), and serotype 4 in 3.3% (3 in IDUs patients and 
1 in the blood transfusion recipients) We detected multiple mfection 
in 4 IDUs patients (3 patients with 1 + 3 serotypes and 1 patient 
with 1 + 6) and in 5 UC patients (2 patients with 1 + 3 serotypes, 2 
with 1 + 4 and 1 patient with 1 + 3 + 5). 
p] Hepatitis C Virus Genotypes in Slovenian 
Patients with Chronic Hepatitis C 
K. Seme I ,  M. Poljak’ , G. LGnitar ’, V. Brinovec 3 ,  S. Stepec ’, 
S. Koren I .  ‘Institute ofMimbiolon, Ljubljana, Slovenia, ’General 
Hospital Celje, Slovenia, Clinical Center, Ljubljana, Slovenia 
Objectives: To determine the distribution of hepatitis c virus 
(HCV) genotypes and the association between HCV genotype and 
&cal variables in Slovenian patients with chronic hepatitis C. 
Metho&. 86 patients h m  all parts of Slovenia, who were consid- 
ered for inclusion in antiviral therapy programs were included in the 
study. HCV genotypes were determined by the reverse hybridization 
assay Inno LiPa HCV I1 (Innogenetics, Belgmm). 
Results: Among 21 patients infected by blood transfusion 19.0% 
had HCV subtype l a  and 81.0% had lb. In 57 patients infected by 
unknown cause subtype l b  was the most prevalent (54.4%), followed 
by l a  (24.6%), 3 (15.8%) and 2 (5.2%). Slovenian patients infected 
with genotypes l a  and 3 were sigmficantly younger than those with 
lb. Levels of viremia were simiiar in patients infected with subtypes 
l a  and l b  and genotype 2, but patients with HCV genotype 3 had 
a sigmficantly lower level of viremia than did patients with other 
genotypes. 
Conclusion: Among patients with chronic hepatitis C in Slovenia 
subtype l b  is the most common HCV genotype. 
Genotypes Distribution in a Spanish University 
Hospital 
MJ. Fresnadillo, A.M. Bkquez, J. Iglesias, I. T r u j h o ,  
M. Cordero ’ ,  E G o d e z  Sanmartin I ,  E. Garcia Shchez, J.E. 
Garcia Sinchez, J.A. Garcia-Rodriguez. ‘Departamento de 
Minobiologia y Departomento de Medicina Interna, Spain, Hospital 
Universifan’o-Facultad de Medicina, Salamanra, Spain 
Objective: The aim of this study was to analyzer the disaibution 
of hepatitis C virus (HCV) genotypes in the Salamanca University 
Hospital area and to establish their therapeutic implications. 
la lb 31 2b (76) TOTAL(%) 
(26.W.) (57.1%) (14.1%) (l.%) 
N - 4 2  N = 8 9  N = 2 2  N = 3  156 
sex: 
MdCS 
Females 
Pucntenl cranmuon 
YCS 
No 
Hlscology 
UnknoWn 
Grrhorls 
Chronic amue hepaaos 
Chronic pemtent hepat. 
36 (33.6) 
6 (12.2) 
27 (33.3) 
15 (20) 
26 (26.5) 
3 (27.3) 
6 (23.1) 
7 (33.3) 
51 (47.7) 
38 (77.5) 
40 (49.4) 
49 (65.3) 
59 (60.0) 
8 (72.7) 
9 (42.8) 
13 (50) 
17 (15.9) 
5 (10.2) 
14 (17.3) 
8 (10.6) 
10 (10.2) 
5 (23.8) 
- 
7 (26.9) 
107 (68.6) 
49 (31.4) 
81 (51.9) 
15 (48.1) 
98 (62.8) 
11 (7.1) 
21 (13.5) 
26 (16.6) 
Methods: 156 serum samples h m  156 patients positive for an- 
tibody to HCV (anti-HCV) and prior PCR positive for HCV-core 
region were tested. RNA extraction and cDNA sintesis was car- 
ried out. Then, nested amplification was performed and amplifica- 
tion products were hybridizated to type/subtype-specific oligonu- 
cleotides probes (la, 15, 2a, 2b, 2c, 3a, 4, 5 and 6) coated to a solid 
phase &ugh an avidin-biotine bridge. The hybrids were detected 
by a standard DEIA reaction (GEN-ETI-KDEIA. Sorin Biomidica, 
saluggia, Idla). 
Results are shown in the table. 
Conclusions: (1) No coinfection was detected. (2) Genotypes lb  
(57.1%), l a  (26.9%) and 3a (14.1%) are prevalent in this spanish area. 
(3) The most fiequent genotype has scanty response to a-interferon 
therapy. 
1 P991 1 Severity of Liver Disease, Genotype, Wraemia, 
Sex and Age of Patients with Chronic 
Hepatitis C 
C. Jebelean, C. Luger, F. Hackl’, B. Sammer, L. Binder, 
M. Haditsch, R. Watschinger, H. Mittermayer. Dept. ofMicwbiology 
and Hygiene, Elisabethinen Hospital Linz, Auttria, ‘Dept. oflntemal 
Medicine I, Elisabethinen Hospital Linz, Austria 
The natural course of hepatitis C and the infiuence of diferent 
factors like age, sex, genotype and viraemia on the progression of 
the disease are not well understood. Genotype Ib has been found to 
be associated with more severe liver &ease by some authors. The 
sigmficance of viraemia in regard to liver disease is undear. 
We determined the HCV genotype using a reverse hybridization 
method (Inno-Lipa, Innogenetics) in 316 patients, in 187 patients 
we quanafied the viremia with a branched DNA assay (Quantiplex 
vers. 2, Chiron). In 145 patients liver biopsies were performed. 
In 316 patients (121 women and 195 men) we found the following 
genotype distribution: subtype lb, 66% (42% women); la, 1Yh (33% 
women); 3a, 8% (33% women); 2a, 2% 4, 1.3% l a  + lb, 3%. 
Hugh viremia levels did not correlate to histology. The mean 
log RNA E q / d  were almost equal for chronic persistent hepati- 
tis (CPH), chronic aggressive hepatitis (CAH) and cirrhosis (CI): 
6.46, 6.30, 6.41 respectively. Patients with hepatocellular carcinoma 
(HCC) showed high viremia titers. Patients infected with subtype lb  
were older than patients infected with subtype 3a (mean 54 and 38 
years, respectively) and had CI in 32% versus 14% of cases. In the 
l b  group women were 8 years older than men and had CI in 37% 
versus 28% of cases. For subtype l b  the median age increased wth 
the severity of the disease. In CPH it was 48 years, in CAH 52 years, 
in CI 61 years and in HCC 66 years. 
Comparison of Amplification and Hybridization 
Protocols to Detect Hepatitis C WNS RNA 
E Garcia, C. Roldin, I. Lopez, E Garcia, Jr., M.C. Bernal, 
A. Leyva, G. Pikdrola, M.C. Maroto. H .  Clinico, Gmnada, fiparirr 
Objective: To compare nested-RT-PCR with an enhanced sin- 
gle-RT-PCR and two diferent DEIA-hybridization protocols. 
Patients and Methods: 80 samples h m  HCV infected pa- 
tients were tested for HW-RNA by three different methods: a) 
nested-RT-PCR &om the 5’UTR region and detection by ethid- 
ium bromide staining (method A); b) enhanced single RT-PCR 
and enhanced DEIA-hybridization (method B); c) enhanced sin- 
gle-RT-PCR and DEIA-hybridization (method C). Total RNA 
was extracted using QUIAGEN spin columns. Primers, probes and 
DEIA-kits were supplied by Sorin Biomedica. 
Results: HCV-KNA was detected in 44 samples by method A. 
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Refered to t h i s  method, sensitivity and speuficity were 98% and 97% 
for method B and 93% and 97% for method C, respectively. 
Conclusion: Enhanced single-RT-PCR from 5'-UTR and en- 
hanced DEIA hybridization shows a good sensitivity and specificity 
and can be used instead of method A, avoiding the fastidious use of 
nested-PCR. 
LP993 I Molecular Typing of Hepatitis C WNS in Hong 
Kong 
E.T.S. Char', M. Ip', J. Tam', N. Leung', A.F.B. Cheng'. 'Dept 
ofMicrobiology, Chinese University ofHong Kong, Prince of Wales 
Hospital, Hong Kong, 'Depf ofMedicine, Chinese University of Hong 
Kong, Prince of Wales Hospital, Hong Kong 
Objectives: To determine the genotypic distribution of hepatitis C 
mfection in Hong Kong. 
Methods: 55 sera samples from patients with hepatitis C virus 
(HCV) infection were collected from the Prince of Wales Hospital, 
Hong Kong during the period of 1995-1996. RNA h m  the sera 
were extracted and subjected to reverse transcription and polymerase 
chain reaction (RT-PCR) using primer sets from the 5' non-coding 
region of the HCV genome [l]. The ampMied products were typed 
by restriction hgment length polymorphxm analysis using enzyme 
pairs HaellI-Rral and Hinf-Mad,  followed by BstUl or ScrFI. [l] 
These enabled types 1-6 and subtypes a or b of types 1-3 to be dis- 
tinguished, as accordmg to the nomenclature proposed by Simmonds 
[2]. The alanine aminotransferase (ALT) level of these patients at the 
time of serum collection were also noted. The HCV RNA level 
from the sera were measured using branched DNA hybridization 
assay for HCV (Chiron Corporation, CA, USA). 
Resultx HCV cDNA were detected in 43 sera following 
RT-PCR. 74% belonged to type 1, 5% type 2 and 21% type 6. 
In subtyping, 94% were subtype l b  and 6% subtype la. All the type 
2 belonged to subtype 2a. 
Conclusions: Predominant subtypes present were of l b  and type 
6. There was little correlation with the ALT levels and the quantity 
of HCV RNA present in the sera of these patients. 
References 
[l] Chan SW, McOmirh F; Holmer EC et d., 1992. 
[Z] Simmondr E Albern A, Alter HJ, et d., 1994. 
Fl Incidence of Hepatitis C WNS in Children with 
Hemophilia in Poland -Analysis of HCV 
GGenotypes 
D. Januszkiewicz' ', J. Wysocki2, J.S. N o d ' .  'Instihrte ofHuman 
Genetics, Polish Arademy of Sciences, Poland, zlnsfitute of Pediatrics Univ. 
$Medical Sciences, Pornah, Poland 
Objectives: To estimate the incidence of HCV infection and to 
analyse HCV genotypes in hemophiliacs in Poland before HCV 
prevention in blood concentrates has been introduced. 
Methods: The study involves 58 children with hemophilia treated 
with more than 10 coagulation factor concentrate h-ansfusions. The 
antibodies against HCV proteins were measured by the second gen- 
eration assay (Organon Teknika). HCV-RNA particles and their 
genotypes were detected by nested PCR method and h e  probe 
assay (Inno-Lipa HCVII). 
Results: Thirty cases (51.7%) were positive for antibody against 
HCV and only s i x  (10.3%) were positive for HCV-RNA as de- 
tected by PCR. All six cases were infected with HCV with a single 
genotype, indudmg type la in one, type Ib in four, and type 3a in 
one patient. Very m e  in Poland HCV genotype 3a has been found 
in one patient receiving transhsions of imported coagulation factor 
concentrates. 
Conclusions: High fi-equency of HCV infection in hemopbihacs 
receiving multiple blood derivatives, which are the sources of in- 
fection. Risk for HCV infection increased with the duration of the 
disease. Most of the HCV mfected hemophiliacs eliminated sponta- 
neously HCV virus &om the peripheral blood. 
T h  work has been sponsored by KBN grant No KBN 4 POSE 
029 08 
I P995 Heterogeneity of Hepatitis C Vitus Genotype 4 
M. Rapicetta ', C. Argentini ', E. Spa& ', S. Dettori 
l? Chionne ' , G. Pellizzer ', E. Renganathan ', M. Angelic0 '. ' Lab. 
of Virol., ISS, Rome, Italy, 'Div. oflnfection Diseases, Hosp. S. Bartolo, 
Vicenza, Italy, 'Medical Research Institute, Univ. $Alexandria, Egypt, 
4Univ. "Tor V i a , " ,  Rome, Italy 
Objectives: HCV infection is world-wide distributed and is char- 
acterized by hgh genome heterogeneity of viruses. DiEerent s t r a i n s  
have been correlated with Werences in biology, pathogenesis and 
epidemiology. The classification of Merent subtypes requires NS5 
and El phylogenetic analysis. By comparison of NS5b region se- 
quences we found high heterogeneity of HCV isolates of genotype 
2 with the identification of possible new variants in an epidemiolog- 
ical study carried out in a West Central AfLican region g. Gen. virol. 
1996,77,2073). The aim of t h ~ s  tudy was to characterize variants of 
genotype 4 for which sequences of NS5b region from only 5 isolates 
are present in data bank. 
Methods: Three epidemiologically and serologically character- 
ized groups of isolates have been studied (NS5b genome region nt 
7975-8196 and El  region nt 900-1350). 
Results: Within 5 isolates from Egypt that were identified as 
4a, the phylogenetic distances were in a range of 0.081541976. 
One isolate exhibited an average genetic distance of 0.2672 in the 
NS5b region (i.e. beyond the 0.21 threshold needed for intrasubtype 
classification). Within the isolates from Tanzania, 3 were classified as 
4a (genetic distance 0.0272-0.1934). Two isolates can be classified 
as a newly described subtype (average genetic distance 0.2667). The 
isolate f b m  Italy belong to subtype 4d (average genetic distance 
0.2365). The 4a isolates f b m  the different Af?ican regions are located 
in three separed phylogenetic clusters. In 
conclusion as we previously observed for genotype 2, also geno- 
type 4 isolates from &can regions exlubit a sigtllficant genetic 
heterogeneity which includes the presence of new subtypes different 
from European subtypes. 
I P996 I Prevalence, Risk Factors and Molecular 
Epidemiology of Hepatitis C Virus Infection in 
the General Population. A Community-Based 
Survey in a Southern Italian Town 
V. Guadagnino', T. Stroffolini', M. Rapicetta3, A. Costantino3, 
L. Kondili ', F. Menniti-Ippolito ', B. Caroleo ' , C. Costa 
G. Grillo 
ofExperim. and Clin. Med., Univ. ofReggio Calabria, Italy, 'Lab. of 
Epidemiol., Lrtituto Superiore di Sanid, Rome, Italy, 'Lab. of Virol., 
Lcfituto Superiore di Sanitri, Rome, Italy, 4Depf. ofMicrobiol., Uniu of 
Reggio Calabria, Italy, 'Clinic of Infecfiow Diseares, Univ. ofhiaples, Italy 
Objectives: We have carried out, a seroepidemiological study in the 
general population of a southern Italian town. 
Methods: The sample was selected from the census by a sys- 
tematic 1:4 random sampling procedure. The participation rate was 
96.6%. 
L. Loiacono', V. Pisani', A. Foci4, M. Piazza5. 'Dept. 
244 Journal of Clinical Microbiology and Infection, Volume 3 Supplement 2 
Results: Among the 1352 subjects enrolled, 170 (12.6%) were 
anti-HCV reactive by ELISA and RIBA (Ortho) with increasing 
trend for age from 1.3% in subjects 1 3 0  yean to 33.1% in those 
>60 years old (P -= 0.01). Females were more likely positive than 
males (€' < 0.05). Alanine aminotransferase concentrations were ab- 
normal in 4.1%. The results of multiple logistic regression analysis 
showed that age 245 years, female sex, use of glass syringes, den- 
tal therapy and anti-HBc positivity were all independent predictors 
of anti-HCV positivity. HCV-RNA was detected by nested PCR 
(5'NCR primers) in 84.7% of sera. HCV type lb  was detected in 
75 subjects (50.7%), type 2b in 1 (0.7%), type 2c in 66 (44.6%), type 
3a in 4 (2.7%), and type 4 in two (1.3%) with no statistical Wer- 
ence (between lb  and 2c) for age and risk factors. Differences were 
present between antibody patterns and l b  or 2c subtypes. 
Conclusions: This work provides one of the highest world-wide 
overall anti-HCV prevalence in a general population with a lkely 
cohort effect. The epidemiological characterization of HCV infec- 
tion in this setting was performed. 
Genotyping of HCV Isolates in Northern Italy: 
Correlation with viral Load and IgM to HCV Core 
Protein 
E Pittaluga, V. Ghisetti, C. De Leo, A. Barbui, S. Varetto, 
P. Piantino, G. Saracco, M. Rizzetto, G. M a r c h .  Clinical 
Microbiology Luboratov Gastroenterology Department, Molinette Hospital 
Turin, Italy 
Objectives: To correlate HCV isolates genotyping with viral load 
and the presence of IgM to HCV core protein h m  a study popula- 
tion of 480 HCV mfected patients (pts) with biopsy-proved chronic 
hepatitis stucled before antiviral theram. 
Methods: HCV genotyping was performed with Line Probe As- 
say. Sera were tested for viral load by branched-DNA @DNA) and 
for IgM to HCV core protein (Abbott HCV IgM EIA 2.0). 
Results: The HCV isolates pattern was as follow: genotype l a  
was foundin 57 pts (12%), Ib in 205 (42.7%). 2a/2c in 95 (19.8%), 
3 in 86 (17.9%), 4 in 32 (6.6%) and 5a in 1 pt (0.2%). Four HCV 
isolates (0.8%) could not be typed. Viral load upds detectable in 440 
(92%) pts. The mean viral load (h4Eq/ml) was for genotype 1, 4.7, 
for genotype 2a/2c, 6.2, for genotype 3,9.6, and for genotype 4,3.8. 
IgM-core were detectable in 345 (72%) pts. The mean viral load for 
IgM negative pts was 5.8 MEq/ml. Semiquantitative evaluation of 
IgM-core (sample optical density/cutoff optical density) showed no 
sigdicant Werence in positive patients when compared for Werent 
HCV genotypes. 
Conclusions: Viral load was significantly hgher in genotype 3 
than in all other genotypes (p < 0.001). No correlation was es- 
tablished among the presence of IgM-core, the wal load and the 
genotype. The presence of a group of viremic pts (n = 135, 28%) 
with chronic liver disease but without detectable IgM-core assesses 
the need of a more sensitive test for IgM to HCV for clinical pur- 
poses. Further study is required to determine how these parameters 
can dect  the clinical outcome of chronic HCV infected patients and 
their trend under antiwal therapy. 
Cellular immune Response in Hepatitis C: A 
New Link to Autoimmunity? 
A.R. Kammer B. Grabscheid M. Cucchiarini J. Reichen ', 
A. Cerny ' . 'Dept. oflnternal Medicine, University Hospital, Bern, 
'Dept. .f Clinical Pharmacology, University of Bern, Switzerland 
Cytotoxic T lymphocytes (CTL) are thought to contribute to viral 
clearance and to liver cell injury during hepatitis C virus (HCV) in- 
fection. CTL recognize anagenic peptides presented on MHC dass 
I molecules. We and others have described HLA dass I-restricted 
HCV-derived CTL epitopes. To analyse HCV-speafic CTL in pa- 
tients with chronic hepatitis C we have focused on a panel of 
HLA-A2-restricted conserved epitopes, two human cytochrome 
P450 (CYP)-derived peptides, that show an amino acid sequence 
related to a HCV epitope (core 178) as well as influenza mahix 
peptide 58-66. 
We were able to detect HCV peptide-speafic CTL responses but 
they were not more reactive in patients with chronic liver disease 
than in healthy seronegative blood donors. In comparison, responses 
against the d u e n z a  matrix 58 peptide were qpficantly more vig- 
orous. Interestingly, our data demonstrate the presence of crossre- 
active CTL induced with the HCV core 178 peptide recognizing 
both human CYP sequences (CYP2A6 and CYP2A7; aa 9-18). Im- 
portantly, we failed to induce CTL with the CYP-derived peptides. 
Our data suggest that a weak CTL response fails to eliminate the 
virus leading to chronic mfection. They also indicate the possibility 
of molecular mimicry at the level of CTL. While self peptides failed 
to induce CTL, the HCV peptide was able to breach tolerance and 
to induce crossreactive CTL against viral and self antigens, possibly 
contributing to HCV associated autoimmunity. 
I P999 I Relation Between Chronic Hepatitis C and 
Diabetes Melli is 
I. Balk', N. Yilmy', N. Turkcapar', H. Y a d .  'Department of 
Infertious Disease, 'Department of Gastroenterology, University of Ankara, 
Faculty of Medicine, 'Department of Endm'noloD, Numune Hospital, 
Ankara, Turkey 
Objectives: We often see type-2 diabetes mellitus (DM) in the 
patients admitted to our clinics for chronic hepatitis C. Therefore, 
we decided to examine the patients with chronic viral hepatitis (B 
and C) for DM and the patients with type-2 DM for HBsAg and 
anti-HCV antibodies. 
Metho*. Group-1 was consisted of 72 patiena with chronic 
hepatitis B and 38 patients with chronic hepatitis C between 1990 
and 1995 (n = 110). The patients who admitted to hospital for 
type-2 DM second half of 1995 consisted of group-2. In these two 
group, we searched the transaminases, other biochemical tests and 
viral hepatitis markers with ELISA method. 
Results: We found type-2 DM in 34.2% of patients with chronic 
hepatitis C and 2.7% of chronic B hepatitis group (p < 0.001). AU 
of type2 DM with chronic hepatitis had not any genetic pred~~posi- 
tion for DM. Type-2 DM was dqposed in 2/3 of the patients after 
chronic hepatitis C was diagnosed. In the patients with type-2 DM, 
rates of HBsAg and anti-HCV were found 5% and 6% respectively. 
The prevalence of HBsAg positiveness is the same as general popula- 
tion value of 5 (4-1 l)%. 6% percentage of anti HCV positiveness in 
clabetics is signtficantly higher than normal population value of 0.6 
Conclusions: We think that chronic hepatitis C infection might 
(0.2-1)% (p < 0.05). 
be risk factor for type-2 DM. 
Jp1ooo1 Different Regimens to Treat Chronic Hepatitis C 
M. Basaras, N. Lombera, B. de las Heras ', C. Lbpez, M. Aragiib, 
R. Cisterna. Dept. Immunology, Mimbioloa and Parasitdon, Bilbao, 
Spain, 'Dept. Medicine, University ofBasque Country, BiZbao, Spain 
Objective. To compare the response to two Merent interferon+ 
therapies in chronic hepatitis C. 
Patients and Methods: Group 1: 15 patients heated for 6 months 
with 3 MU of IFNa-2a (Roferon-A; Roche Laboratories) given 
Hepatitis G 245 
subcutaneously three times a week. Group 2: 18 patients treated for 
12 months at the same dosage. 
Serum RNA was detected using primers derived fmm the 5' 
non-coding region. To investigate the replication in peripheral blood 
mononuclear cells (PBMC), we performed a specific reverse tran- 
scription with primers of sense and antisense polarity. Genotypes 
were identified using a combination of two techniques, PCR and 
DEIA (DNA enzyme immunoassay). 
Results: In group 1, there were 7 nonresponders patients. Five 
out of 7 patients had both genomic and antigenomic HCV sequences 
in PBMC and were positive in serum at the end of therapy (3 
patients had genotype lb, one patient had lb, 3a and one patient 
had 3a). Three patients were partial responders, positive in serum 
and one of them showed replication in PBMC (2 patients infected 
with genotype l b  and another one with lb, 3a). Four patients were 
sustained responders, negative in serum and with no replication in 
PBMC (2 patients with genotype la, one patient with 3a and one 
with la, lb). 
In group 2, treatment was discontinued in 6 patients because of 
adverse events. Two patients were nonresponders (genotype lb), pos- 
itive in serum and with replication in PBMC. Three patients were 
partial responders (2 of them with genotype 3a and one with geno- 
type lb), positive in serum and with no replication. Five patients 
were sustained responders (2 patients with genotype 3a, one patient 
with la, one with la, 3a and one was no determined). 
Conclusions: Longer IFN therapy at the same dosage enhance 
the rate of sustained responses in patients with chronic active hep- 
atitis. Furthermore, genotype 3a was more sensitive to IFN therapy 
than genotype lb. Finally, the presence of replicative intermediate in 
PBMC means nonresponse. 
improvement was observed. In future we are planning combined 
therapy with r-IFN-alfa and nucleoside analogue rivabirin. 
I PI002 I Evolution of Hepatitis C Virus Genotypes in La 
A. Guerra-Neira, €? Campo, E Mesa, €? Soler, C. Ladrh de 
Guevara. LA Paz Hospital, Madrid, Spain 
We studied 120 HCV-genotypes identified between April and 
December of 1996 (Study 2) and compared them with 75 
HCV-genotypes identified before this period, studied in a previous 
work (Study 1). 
Sera have been tested by a h e  probe assay, a specific DNA hy- 
bridization test based on the reverse-hybridization principle. Study 
1 was performed by a manual test (INNO-Lipa HCV, Innogenetics) 
and Study 2 by an automatic one (INNO-Lipa HCV 11, Innogenet- 
ics). 
Paz Hospital, Madrid 
Results are shown in the following table: 
Study 1 Study 2 
No 75 1 20 
l b  69% (52) 52.5% (63) 
1s 18.6% (14) 19% (23) 
2b 1.3% (1) 3.3% (4) 
3 6.6% (5) 7.5% (9) 
Co infernon 2.6% (2) 17.5% (21) 
The most frequent HCV-genotype is s d l  lb. Genotype l a  main- 
tains the same proportion and it increases significantly in coinfected 
sera, mostly with genotype l b  (50% of coinfection la/lb). 
Histological Findings in Anti-HCV Positive 
Children with Persistently Normal ALT Levels 
1 PI001 I Efficacy of Long TEHM Recombinant 
Interferon-ALFA in Patients with Chronic 
Hepatitis C 
T. Wohukowska-Gpicka, A. Kalu+ski, J. Kupi, 
M. WGniewska-Ligier, D. Dworniak, J. Planeta-Malecka. 
Departamat of Gashoenferology and Infectious Diseases Military 
University, k d d f ,  Poland 
Lj. Konstantinovit, i. Rankovit, M. Krstit, V Kostit, M. Vrbit, 
G. Tasit, D. Dimov, D. Mihailovit, S .  Tritkovit. Clinicfor Infectious 
KC N i f ,  Yugoslavia 
Diseases, KC N S ,  Yugoslavia, Clinicfor Clinicfor Minobiology Depattament ofPediahics, Po'ish Mother's 
At the present time, recombinant interferon-alfa (r-IFN-alfa) re- 
mains the preferred treatment for chronic HCV infection. In our 
prospective study we wanted to establish the effect of treatment with 
r-IFN-alfa in patients with chronic hepatitis C. A group of 19 pa- 
tients was studied limited increased activity of ALT, YGT, bilirubin, 
and histologic evidence of chronic hepatitis. The source of con- 
tamination was inmavenous drug addiction in 11, blood transfusion 
or administration of blood products in 3 and unknown in 3. All 
patients (aged 18-50), which selected for this study were HCV pos- 
itive and had histologic signs of moderate to middle intense chronic 
active hepatitis C. They were all treated with r-IFN-alfa 3 MU 
thrice weekly for 6 months. The results of therapy were followed 
clinically, biochemically, histologically, serologically (ELISA test and 
HCV 2nd pen). In all patients a transient granulocytopenia and thro- 
mocytopenia were observed and in 7 (36.8%) flue like syndrome, 
myalgia and anorexia during the first week of therapy. In 7 (36.8%) a 
transient normallsation of ALT was established but histologic picture 
remained unchanged at the end of therapy. All patients remained 
anti HCV positive in blood and after the secession of therapy. In 
3 patients (15.7%) the biochemical test aggravated. In two patients 
the therapy was repeated after 12 months but the results remained 
unchange. 
Conclusion: In our patients the interferon treatment was success- 
ful in 36.8% patients. In spite of transient normalisation ofbiochem- 
ical test anti HCV in blood remained persistent and no histologic 
HCVinfections is associated with a high rates viremia and chronic 
progressive liver disease. Many asymptomatic patients have been 
identified, who possess antibodm, biopsy proved chronic hepatitis 
and their biochemistry may be normal. 
The aim of thu; study was to assess histological features in asymp- 
tomatic anti-HCV positive patients who had had normal ALT levels 
during at least 6 months of follow up. 
Methods: 20 asymptomatic anti-HCV positive children (age 
4-12 years) underwent penutaneous biopsy to perform histologic 
dugnosis based on Knadell's scores. In chddren with histological 
findings, chronic hepatitis was considered as d (score 1-3), 
chronic persistent hepatitis (score 4-7) and chronic active hepatitis 
Results: Histological findings shows normal liver in 5 children, 
minimal changes in 6 children, chronic hepatitis persistens in 8 chil- 
dren and active chronic hepatitis in l child. 
(1) In analyzed children high rate frequency (45%) of chronic liver 
(2) Liver biopsy should be performed in all anti-HCV positive chil- 
(score 8-10), 
Conclusions: 
disease was found. 
dren for assessing the degree of damage of liver. 
